On January 11, in Ahmedabad, India, a few months after the school was closed due to the outbreak of the Coronavirus Disease (COVID-19), the authorities reopened the 10th and 12th grade schools. Students wear protective masks to attend classes because They keep social distance. 2021. Reuters/Amit Dave/File Photo
Reuters, Bangalore, September 28-On Tuesday, the Indian drug regulator allowed vaccine manufacturer Serum Institute to recruit children aged 7-11 to participate in the trial of the COVID-19 vaccine from the US drugmaker Novavax (NVAX.O) as the country prepares to protect children from the novel Coronavirus.
This South Asian country has injected more than 870 million doses of vaccines for adults of its nearly 1.4 billion population.
A subject expert panel of the Central Pharmaceutical Standards Control Organization said: "After detailed review, the committee recommended that subjects in the 7 to 11 age group be recruited in accordance with the agreement."
The Serum Institute has tested its COVID-19 vaccine Covovax, a domestic version of Novavax vaccine, in the age group of 12-17 years, and provided safety data for the first 100 participants.
The Novavax vaccine has not yet been approved by Indian health authorities. Earlier this month, the head of the Serum Institute, Adar Poonawalla, said that he expects Covovax to be approved for use in people under the age of 18 in January or February next year.
So far, only the drug maker Zydus Cadila (CADI.NS) DNA COVID-19 vaccine has been approved for emergency use in India and can be used in adults and children 12 years and older.
Our standard: Thomson Reuters Trust Principles.
Subscribe to our daily featured newsletter to receive the latest exclusive Reuters reports sent to your inbox.
Reuters, the news and media division of Thomson Reuters, is the world's largest multimedia news provider, reaching billions of people around the world every day. Reuters provides business, financial, domestic and international news directly to consumers through desktop terminals, world media organizations, industry events and directly.
Rely on authoritative content, lawyer editing expertise, and industry-defining technology to build the most powerful argument.
The most comprehensive solution to manage all complex and expanding tax and compliance needs.
The industry leader in providing online information for tax, accounting and financial professionals.
Access unparalleled financial data, news, and content with a highly customized workflow experience on desktop, web, and mobile devices.
Browse an unparalleled combination of real-time and historical market data and insights from global resources and experts.
Screen high-risk individuals and entities around the world to help discover hidden risks in business relationships and interpersonal relationships.
All quotes are delayed by at least 15 minutes. Please see the complete list of exchanges and delays here.